Metoclopramide Tablet
FDA Recall NDC 60687-620
Latest: Class II · Status: Ongoing · Initiated Oct 06, 2026 · 1 enforcement report
Active & Historical Enforcement Reports
The FDA has identified 1 recorded enforcement report(s) associated with Metoclopramide (NDC 60687-620). A significant event, classified as Class II, was initiated on Oct 06, 2026 by American Health Packaging. The reported reason for this action was: "Presence of Foreign Tablets/Capsules"
This recall is currently ONGOING. Healthcare providers and patients are advised to check their inventory immediately against the affected codes provided below.
This recall is currently ONGOING. Healthcare providers and patients are advised to check their inventory immediately against the affected codes provided below.
Reported Recall Events
Class II Ongoing
Presence of Foreign Tablets/Capsules
Oct 06, 2026
Oct 21, 2026
5,363 cartons
Recall Profile & Regulatory Data
Event ID
100100
Classification
Class II
Enforcement Status
Ongoing
Recalling Firm
American Health Packaging
Voluntary / Mandated
Voluntary: Firm initiated
Distribution Pattern
US Nationwide
Product Description
Metoclopramide Tablets, USP, 5 mg, 100 Tablets (10 x 10), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 60687-620-01; NDC Unit Dose: 60687-620-11
Batch or Lot Expiration Information
Lot# Lot 1028135, 1029555; Exp. Date 07/31/2027
Affected Packages Involved in this Recall
60687-620-11Metoclopramide
60687-620-01Metoclopramide
60687-631-11Metoclopramide
60687-631-01Metoclopramide
About FDA Recall Enforcement Reports
FDA recall data documents classified recall actions associated with a product. Most recalls are limited to specific lots, batches, or package configurations rather than every unit of a drug.
If a recall is listed for an NDC, review the affected lot information and package details carefully. Patients and healthcare professionals should confirm whether a specific product in hand matches the lot or package information before assuming it is affected.
